If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 6 Apr: IAVI begins first-in-human Phase 1 trial of single-dose Marburg virus vaccine candidate
• 25 Mar: Advancing outdoor mosquito biting tools: IVCC and Molecular Attraction launch new collaboration
• 14 Apr: Closing the Gap Between Impact and Innovation
• 16 Apr: Going the distance: House-to-house mobilizers sustain progress on malaria vaccine rollout in Nigeria
• 8 Apr: Global partnership delivers first real-world evidence that new tools can accelerate elimination of relapsing malaria
• 18 Mar: MMV aims to tackle some tough malaria challenges with three new AI projects in drug discovery and development
• 26 Mar: Collaborative science, new treatments and stronger research leadership: PAMAfrica’s legacy
• 31 Mar: Free AI drug discovery platform aims to level the playing field for global health research
• 4 Mar: Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
• 23 Mar: DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement
• 9 Apr: Dr Ayoade Alakija Appointed to the Accra Reset initiative
• 15 Apr: Nordic Conference Report: How The Nordic Vaccine Ecosystem Can Reach Its Full Potential
• 26 Mar: IVI and Brazil sign letter of intent supporting the establishment of the BRIGHT Fund, advancing a Global South-led model for health innovation
• 10 Feb: EVI supports first-in-human clinical trial of novel Nipah virus vaccine
MDGH
• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction
PDP Funder News/Announcements
• 3 Apr: Wellcome position paper on Horizon Europe 2028–2034. Wellcome
• 3 Apr: Announcement of Changes in the Selection Committee. GHIT
• 7 Apr: Commission announces new global health commitments at One Health Summit. European Commission
• 20 Mar: The TB response must work for everyone – including those it has historically overlooked. Unitaid
• 26 Mar: Learning from history to find success in a new TB vaccine. Gates Foundation
• 30 Mar: GHIT Fund and Thailand Science Research and Innovation to strengthen partnership through co-funding initiative. GHIT
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 10 Mar: Tools to fight AMR exist, but industry-wide action is needed to tilt the battle against superbugs. Access to Medicines Foundation
• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies
Related Press Releases/ Announcements/Articles
• 1 Apr: The lenacapavir paradox: why a promising prevention tool raises difficult questions about African HIV response priorities. The Lancet
• 1 Apr: NeoSep1 trial widens to find better sepsis treatment for newborns. Nature
• 1 Apr: Hope for control of a centuries-old epidemic. Nature
• 1 Apr: Africa Urged to Explore Innovative Financing to Strengthen Health Research and Development. Health Business
• 2 Apr: Defensive manoeuvres: the vaccines the military made. Gavi
• 2 Apr: Accelerating Action for Pandemic Preparedness in 2026: Joint Statement by IPPS, CEPI, FIND and DNDi. IPPS
• 2 Apr: Congo says its mpox outbreak is over after 2 years and more than 2,200 suspected deaths. AP
• 2 Apr: Civil Society Calls for Greater Engagement in Rollout of HIV Prevention Drug Lenacapavir As Global Tensions Grow. Health Journalists Network
• 3 Apr: Slasher sequel: Trump again proposes major cuts to U.S. science spending. Science
• 3 Apr: Exclusive: US upends global supply program for malaria and HIV amid warnings of gaps. Reuters
• 3 Apr: Accra Reset announces 18-member high-level panel to reform global health governance. My Joy Online
• 3 Mar: Shaping markets for health: How the Global Fund plans to secure affordable health products for the future. AIDSPAN
• 3 Mar: Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update. Nature
• 4 Mar: First global "early warning system" for dengue launches. LSHTM
• 4 Mar: State Department eyes tuberculosis breakthroughs. Devex
• 4 Mar: mRNA vaccines and therapeutics beyond COVID-19: A review of the global clinical development landscape, low- and middle-income countries involvement and relevance to their contexts. Human Vaccines & Immunotherapeutics
• 5 Mar: Gilead and South Africa are negotiating a license for local production of new HIV drug. STAT
• 5 Mar: Language and geographical bias limits global health research. BMJ
• 5 Mar: South Africa seeks local production of Gilead's HIV prevention drug. Reuters
• 5 Mar: One Billion Tests: Turning India’s Diagnostic Boom into Public Health Intelligence. IHP
• 6 Apr: Lenacapavir and the Access Impasse: Understanding Why Gilead Said No to MSF. Health Quotient
• 6 Apr: Nigeria imports 70% of its medicines – why local manufacturing doesn’t meet demand. The Conversation
• 6 Apr: Trump signals no letup in cuts to US foreign assistance. Devex
• 7 Apr: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say. STAT
• 7 Apr: Harnessing The Power of Science and Scientific Collaboration to Improve Health Outcomes. UNDP
• 7 Apr: R&D roadmaps for pathogen families to reduce uncertainty about the next pandemic and boost coordinated global R&D preparedness. WHO
• 7 Apr: Flurry of Pledges at G7 One Health Summit. Health Policy Watch
• 7 Apr: Integration Without Loss both at Local and Global Levels: Lessons from the MSF–Gilead Lenacapavir Case. The Global Advocacy Data Hub
• 7 Apr: Insecticide resistance in South American mosquitoes portends trouble for malaria control. CIDRAP
• 7 Apr: Global Dx, lab, pharma players form coalition to tackle infectious disease diagnoses, treatment. 360Dx
• 7 Apr: Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats. Biomeriuex
• 8 Apr: R&D roadmaps for pathogen families to reduce uncertainty about the next pandemic'. CEPI
• 8 Apr: Strengthening One Health through coordinated action on implementation, science, policy and financing. WHO
• 8 Apr: Africa CDC Secures Over US$250 Million to Advance Africa’s Global Health Security Agenda at the Lyon One Health Summit in Lyon (France). Africa CDC
• 9 Apr: Why mpox outbreaks can change course and what we can do about it. Gavi
• 9 Apr: Transforming WHO: incremental reform is no longer sufficient. The Lancet
• 9 Apr: The Global Fund veteran building Africa CDC's pooled procurement platform. Devex
• 9 Apr: How UK aid spending fell sharply in 2025. Devex
• 9 Apr: G7 One Health Summit launches global diagnostics initiative, and other health stories. WEF
• 9 Apr: The incentives for drug manufacturing in Africa aren’t working. Devex
• 9 Apr: Next-Generation Monoclonal Antibodies: Another Promising Approach to Malaria Prevention. NEJM
• 9 Apr: Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial). BMJ
• 9 Apr: Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats. CIDRAP
• 10 Mar: New funding opportunity to accelerate infectious disease trials. NIHR
• 10 Apr: Record ODA Cuts: Top Donors Slash Aid as Global Health Risks Grow. Health Policy Watch
• 10 Apr: Shifting Global Health R&D Funding: Opportunities in a Changing Landscape. MSF Access Campaign
• 10 Apr: A shot of hope: How the malaria vaccine is helping to change lives in Kenya. Vaccines Kenya
• 11 Mar: Global Fund Faces $5bn Shortfall as France Slashes Support, EU Delays Pledge. Health Policy Watch
• 11 Mar: Our global health architecture needs urgent reform: the Pandemic Agreement could be the catalyst. Gavi
• 11 Mar: New malaria vaccine shows promise in preclinical trials. MedicalXpress
• 11 Mar: WHO releases new target product profiles for urgently needed antibiotics. WHO
• 11 Mar: UK health authorities join forces to champion foreign infectious disease trials. Clinical Trials Arena
• 11 Mar: Indonesia in the BRICS: What It Means for Global Health. Think Global Health
• 11 Mar: Experts fear ‘unethical’ vaccine trial in Africa is ‘prototype’ for US studies under RFK Jr. The Guardian
• 11 Mar: African countries are signing bilateral health deals with the US: virologist identifies the ‘red flags’. The Conversation
• 11 Mar: Dengue vaccine remains 80.5% effective against severe cases after five years. MedicalXpress
• 11 Mar: WHO targets new antibiotics to fight hospital ‘superbugs’. The Telegraph
• 11 Mar: Nipah virus: a regional threat south Asia keeps underestimating. The Lancet
• 11 Mar: Using mosquitoes to vaccinate bats could curb the spread of deadly diseases. Nature
• 11 Mar: Global research agenda on knowledge translation and evidence-informed policy-making: prioritizing research for better decision-making. WHO
• 12 Mar: The global health reform debate’s dangerous blindspot. Unitaid
• 12 Mar: Gates Foundation grant moves AltraTech molecular point-of-care HIV viral load test closer to market. 360Dx
• 12 Mar: Scientists turn mosquitoes into "flying vaccines. Gavi
• 12 Mar: Antimicrobial resistance: Pharma pipeline projects drop by over a third. The BMJ
• 12 Mar: Butantan dengue vaccine estimated to be 81% effective against severe disease for at least 5 years. CIDRAP
• 13 Apr: The world is running out of antibiotics that work. Drought is making it worse. Gavi
• 13 Apr: Ending HIV requires research in and with South Africa. The Lancet
• 13 Apr: When the medicine runs out: AMR, antibiotic shortage, and the children being left behind. IHP
• 13 Mar: The benefits to Americans of US-supported international HIV research. Health Affairs
• 14 Apr: Lewin denies shutdown of global health supply chain. Devex
• 14 Apr: Evaluation of the COVAX Facility, COVAX Advance Market Commitment (AMC) and COVAX pillar delivery efforts. Gavi
• 14 Apr: The Way Forward for Global Health: The Futures Summit. CSIS
• 14 Apr: Tackling the global health research financing emergency to sustain national health research ecosystems. The Lancet
• 14 Apr: One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access. Health Policy Watch
• 14 Apr: LSTM joins global consortium accelerating the development of new tuberculosis treatments. LSTM
• 14 Apr: CEPI and PAHO expand partnership to strengthen regulatory systems and vaccine safety across the Americas. CEPI
• 15 Apr: US and Global Fund ramp up support for HIV prevention jab. Devex
• 15 Apr: Funding Cuts Challenge Malaria Vaccination Initiatives. Medscape
• 15 Apr: WHO says vaccinations saving millions in Africa, but aid cuts threaten progress. ABC News
• 15 Apr: Call for US Congressional Oversight on Bilateral Health Agreements. Health Policy Watch
• 18 Mar: New vaccine to stop deadly meningitis epidemics confirmed to be safe. Gavi
• 18 Mar: Accelerating research and development of new vaccines against tuberculosis: 5-year progress on the global roadmap. The Lancet
• 17 Apr: A New Global Health Architecture: Maximising Health Returns. Daniel Reidpath
• 18 Apr: Tackling the global health research financing emergency to sustain national health research ecosystems. The Lancet
• 19 Mar: 180 000 infections in 2024, 47 000 by 2045 — if SA rolls out the twice-a-year HIV prevention jab fast enough. Bhekisisa
• 20 Mar: Gilead could potentially end HIV. But will it be able to?. PharmaVoice
• 20 Mar: Evidence into action: How do we make a new TB treatment with staying power?. FHI 360
• 20 Mar: UK lays out the development priorities of a shrinking aid budget. Devex
• 21 Mar: Global tuberculosis response off track: urgent priorities to end the world's top infectious killer. The Lancet
• 22 Mar: Needed: Greater Accountability on Pathogen Data Sharing, To Minimize Biosecurity Risks & To Boost Preparedness. Geneva Health Files
• 22 Mar: This lab that's determined to discover new drugs isn't where you might expect. NPR
• 23 Mar: Closing the persistent gap in TB diagnosis. GHTC
• 23 Mar: Tense Start to Final Pandemic Agreement Talks as Africa Rejects New Draft Text. Health Policy Watch
• 23 Mar: Pandemic Talks: Europe is Blocking Health Equity – And It Knows It. Health Policy Watch
• 23 Mar: New WHO recommendations for tuberculosis diagnosis. The Lancet
• 23 Mar: Intelligenome, Cornell to develop low-cost point-of-care tuberculosis diagnostic. 360Dx
• 23 Mar: Diagnostic innovations to find the missing millions with tuberculosis. The Lancet
• 23 Mar: The case for ambition: Why countries must move boldly on Near Point-of-Care TB Diagnostics. PLOS
• 23 Mar: New tongue-swab TB test could help eradicate the disease, WHO says. Forbes
• 23 Mar: The aid system is ‘unfit for purpose’. So what comes next?. The Telegraph
• 23 Mar: Here's what we know about Trump's expanded Mexico City Policy. Devex
• 23 Mar: African CSOs call for equity as pathogen access talks hit final stretch. Devex
• 24 Mar: Global Vaccine Security Still Needs International Cooperation: Are Middle Powers the Key?. CGD
• 24 Mar: Undetected Tuberculosis Crisis Plagues Europe; WHO Rolls Out New Diagnostic Tools. Health Policy Watch
• 24 Mar: WHO recommends new diagnostic tools to help end TB. WHO
• 24 Mar: Strengthening Access Planning: The Launch of Lenacapavir in Zambia. AVAC
• 24 Mar: Bridging the Gap Between Science and Communities: Delivering Accessible Information and Leading Global Conversations. AVAC
• 24 Mar: The world’s deadliest infectious disease is on the rise in the US. Vox
• 24 Mar: Sustaining Tuberculosis Innovations to Counter Foreign Aid Cuts. Think Global Health
• 24 Mar: New therapies are transforming treatment for drug-resistant TB – so why aren’t people getting them?. The Telegraph
• 24 Mar: New vaccines could help us consign tuberculosis to history: here’s how we can do it. Gavi
• 25 Mar: Multilane Procurement Amid the America First Health Agenda. Think Global Health
• 26 Mar: Boron plays a key role in new sleeping sickness drug. Chemistry World
• 26 Mar: Have your say on transforming global health. WHO
• 26 Mar: US Withdrawal of Global Health Funding is ‘Public Health Emergency of International Concern’. Health Policy Watch
• 27 Mar: NIH restrictions on research partnerships with foreign institutions significantly impacted 1 in 4 U.S. scientists. STAT
• 27 Mar: Global Health Watch: Pandemic Treaty Tensions, Public Health Emergency, CDC Instability & Global Fund’s Role in Bilateral Health Deals. AVAC
• 27 Mar: Study reveals genetic evolution of major malaria vector species in South America. News Medical
• 27 Mar: AfDB, Gates propose boosting government liquidity for health products. Devex
• 27 Mar: Bavarian Nordic submits data to EMA to extend mpox and smallpox vaccine approval to children aged 2-11 years. Bavarian Nordic
• 28 Mar: Another global health crisis is gaining momentum. We need to be prepared. The Hill
• 28 Mar: New Funding Models Needed as Global Health Faces Growing Financial Strain. Health Policy Watch
• 28 Mar: Building momentum at the African Medicines Agency. The Lancet
• 28 Mar: WHO Member States agree to extend negotiations on key annex to the Pandemic Agreement. WHO
• 28 Mar: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization. STAT
• 30 Mar: Vaccine-induced mouse antibodies targeting Plasmodium falciparum PfVFT antigen inhibit blood stages through multiple mechanisms. Nature
• 30 Mar: A New Compact for Health Financing: From Principle to Practice. CGD
• 30 Mar: Pandemic deal hangs in the balance as countries deadlocked over vaccine details. Politico
• 30 Mar: Decentralizing testing capacity of mpox in Africa: a narrative review. The Lancet
• 30 Mar: World-first discovery of noma-linked bacteria opens path to early diagnosis and prevention . Liverpool School of Tropical Medicine
• 31 Mar: New Open Source AI Platform Aims to Accelerate Malaria Drug Discovery. Health Policy Watch
• 31 Mar: What Will It Take for Development Agencies to Stay Effective in a Changing Landscape?. CGD
Upcoming Meetings/ Webinars
--------------------------